Treatment-Resistant Depression and the Use of Spravato (Esketamine) in Clinical Practice
Fri, Jul 24
|The Crowne Plaza
Time & Location
Jul 24, 2026, 8:30 AM – 12:00 PM EDT
The Crowne Plaza, 801 Greenwich Ave, Warwick, RI 02886, USA
Guests
About the Event
Presented by Samuel Kaufman, MSN, APRN, PMHNP-BC
8:30-9:00am - Registration and Buffet Breakfast
9:00am-12:00pm - 3 hour Presentation
Description
This 3-hour seminar is designed for mental health professionals seeking a deeper understanding of treatment-resistant depression (TRD) and the evolving role of intranasal esketamine (Spravato) withinmodern psychiatric practice.
Participants will explore the neurobiological foundations of major depressive disorder (MDD) and TRD, including disruptions in neuronal signaling, impaired synaptic plasticity, Default Mode Network (DMN) dysregulation, glutamatergic dysfunction, and stress-related neurotoxicity. The seminar will also review emerging theories regarding neuroplasticity and the role of maladaptive neural network activity in chronic depressive illness.
Schedule
30 minutesRegistration+ Buffet Breakfast
3 hours3 Hour CEU Presentation
Tickets
Treatment-Resistant Depression
Treatment-Resistant Depression and the Use of Spravato (Esketamine) in Clinical Practice
From $50.00 to $75.00
$75.00
+$1.88 ticket service fee
$50.00
+$1.25 ticket service fee
Total
$0.00